Clinical Trial Update: Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating optimization of immunotherapy for advanced melanoma in the Brazilian public health system; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Melanoma Metastatic, Melanoma Recurrent | Phase 2 | Status: ACTIVE_NOT_RECRUITING